Ann (Kasia) Nowinski

Kasia Nowinski is a Principal Scientist at Pfizer in the Pharmaceutical Sciences department. She is a leader in formulation and drug product development with industry and research experience in biotechnology, process engineering, and analytical characterization. Her experience includes protein formulation and drug product development for antibodies and antibody-drug conjugates in liquid, frozen, and lyophilized dosage forms. Kasia serves a member of the BioPhorum Forced Degradation Workstream team and has contributed to a group publication on the use of forced degradation studies to assess comparability of biopharmaceuticals. She also is an active member of the IQ Characterization and Control of Particulate Matter in Biotherapeutics Working Group.